ABEONA THERAPEUTICS INC. — Cash Flow Charts
63 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-26.6% -$4M
$-18M
Free Cash Flow↓-90.3% -$547K
$-1M
Investing Cash Flow↓-49.4% -$9M
$10M
Financing Cash Flow↓-32.0% -$2M
$4M
Capex↑+90.3% +$547K
$1M
Stock-Based Comp↑+30.9% +$604K
$3M
Debt Issued
$0
D&A↑+60.1% +$324K
$863K
SBC Allocated Expense↑+30.9% +$604K
$3M
SBC Unrecognized Cost
$7M